Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

BLPH

Bellerophon Therapeutics (PK) (BLPH)

Bellerophon Therapeutics Inc (PK)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:BLPH
FechaHoraFuenteTítuloSímboloCompañía
04/03/202416:25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BLPHBellerophon Therapeutics Inc (PK)
01/03/202409:04Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:BLPHBellerophon Therapeutics Inc (PK)
12/02/202414:44Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:BLPHBellerophon Therapeutics Inc (PK)
14/11/202315:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:BLPHBellerophon Therapeutics Inc (PK)
06/11/202315:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:BLPHBellerophon Therapeutics Inc (PK)
07/02/202011:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLPHBellerophon Therapeutics Inc (PK)
27/01/202015:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
07/01/202007:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BLPHBellerophon Therapeutics Inc (PK)
27/12/201907:26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:BLPHBellerophon Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:BLPH

Su Consulta Reciente